Wednesday, June 22 11:15am - 12:15pm
Room 204
CROs and Biotechs: A roadmap to strategic partnership
- The story so far: How biotech industry uses CROs to achieve drug program objectives
- From discovery to early clinical phase: Strategic role of CROs in winning the challenges
- Evaluating the advantages of an integrated drug discovery partner
Case study: Syngene’s experience of working with global pharmaceuticals and biotechs in moving across phases
- Discovery
- Preclinical
- Clinical work
Speaker:
Alan Collis, Vice President, Integrated Drug Discovery Services, Syngene International Ltd
Heather Sugrue, Vice President, Integrated Drug Discovery Services, Syngene International Ltd
Hosts:
